Augnition Labs LLC

New York, NY · Medtech · Private

Augmem™ digital biomarker platform—a cognitive assessment tool using pattern separation tasks combined with AI models to detect early signs of Alzheimer's Disease

Grants
$2.9M
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Augmem: A Novel Digital Cognitive Assessment for the Early Detection of Alzheimer's Disease$1,965,523
Federal grantDepartment of Health and Human Services · Phase II · Augmem: A Novel Digital Cognitive Assessment for the Early Detection of Alzheimer's Disease$960,670
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
910THROMBOLEX, INC.—$46M
911SkinAxis LLC——
912PEDIALYDX INC——
913Augnition Labs LLC——
914DOMICELL INC.——
915CREATHADH ENERGIES, LLC——
916ORTHOCARE INNOVATIONS, LLC—$6.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.